Skip to main content
TipRanks
Go Ultimate75% OFF

MPH Health Care AG (93M1) AI Stock Analysis

6 Followers
DE:93M1

MPH Health Care AG

(XETRA:93M1)

Select Model
Rating:72Outperform
Price Target:EUR 37.00â–²(8.19% Upside)
Action:reiterated
Date:11/17/26

MPH Health Care AG achieves a moderate overall score driven by its extremely attractive valuation, massive dividend yield, and rock-solid balance sheet with negligible debt. The stock is currently enjoying a strong technical uptrend. However, the score is significantly constrained by severe weaknesses in cash flow conversion and heavily overbought momentum indicators, highlighting potential risks in earnings quality and near-term price stability.

Positive Factors
Conservative balance sheetVery low leverage gives MPH strong financial flexibility and reduces the burden of interest and refinancing obligations. This supports resilience through weaker portfolio periods and preserves capacity to manage investments or absorb valuation volatility without relying heavily on additional borrowing.
Negative Factors
Highly erratic revenueThe sharp reported revenue decline and history of unusually large revenue swings reduce confidence in the durability of MPH’s top-line performance. Such volatility makes underlying earnings harder to forecast and complicates assessment of whether recent profitability reflects a repeatable operating trend.

MPH Health Care AG (93M1) vs. iShares MSCI Germany ETF (EWG)

-25%0%25%50%75%100%125%150%DE:93M1+128.62%EWG+7.62%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 146.42M
Dividend Yield
14.62%
Average Volume (3M)
2,411
Price to Earnings (P/E)
1.4
Beta (1Y)
0.74
Revenue Growth
-62.35%
EPS Growth
―
Country
Germany
Employees
2
Sector
Financial
Sector Strength
68
Industry
Asset Management

MPH Health Care AG Business Overview & Revenue Model

Company Description

MPH Health Care AG is a German-based investment firm with a primary focus on the healthcare sector. The company's portfolio includes the production and distribution of medicinal products designed to treat serious illnesses like cancer, HIV, and vario...

How the Company Makes Money

MPH Health Care AG primarily makes money through its role as a holding company that owns stakes in healthcare-related businesses. Its earnings are typically generated from (1) dividends and profit distributions received from portfolio companies (when...

MPH Health Care AG Financial Statement Overview

Summary

The company maintains a fortress balance sheet with negligible debt and substantial equity. However, financial performance is heavily weighed down by contracting profit margins and severely weak cash flow generation, raising concerns about the underlying quality of its reported earnings.

Income Statement

65Positive

Balance Sheet

90Very Positive

Cash Flow

30Negative
Financial statement breakdown
BreakdownTTMMar 2026Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue358.93M364.30M6.11M7.24M6.85M4.36M
Gross Profit358.90M364.30M6.11M125.94M6.80M4.01M
EBITDA112.79M34.10M33.32M30.36M29.68M-9.05M
Net Income107.05M29.30M32.04M29.54M29.11M-8.96M
Balance Sheet
Total Assets266.68M258.09M291.06M266.35M236.99M198.00M
Cash, Cash Equivalents and Short-Term Investments2.82M1.37M1.20M5.10M3.82M4.44M
Total Debt15.37M11.63M10.56M13.05M12.99M4.05M
Total Liabilities18.27M14.68M13.19M15.39M15.57M5.69M
Stockholders Equity248.41M243.41M277.87M250.97M221.42M192.31M
Cash Flow
Free Cash Flow0123.01K1.83M-2.02M-170.41K-1.28M
Operating Cash Flow11.02M130.88K1.83M-2.02M-164.79K-1.28M
Investing Cash Flow-3.79M-3.29M3.40M5.40M-8.96M6.37M
Financing Cash Flow-11.85M-6.85M-7.70M7.74M-3.02M-3.61M

MPH Health Care AG Technical Analysis

Technical Analysis SentimentPositive
Last Price34.20

Price Trends

50DMA28.20Positive
100DMA26.35Positive
200DMA22.62Positive

Market Momentum

MACD1.48Negative
RSI80.00Negative
STOCH91.58Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:93M1, the sentiment is Positive. The current price of 34.20 is above the 20-day moving average (MA) of 29.66, above the 50-day MA of 28.20, and above the 200-day MA of 22.62, indicating a bullish trend. The MACD of 1.48 indicates Negative momentum. The RSI at 80.00 is Negative, neither overbought nor oversold. The STOCH value of 91.58 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DE:93M1.

MPH Health Care AG Peers Comparison

Overall Rating

UnderperformOutperform
Sector (68)

Financial Indicators

DE:93M1 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
DE:93M1DE:93M172OutperformEUR 146.42M1.3743.53%14.62%-62.35%―
Sector *68Neutral$18.00B11.429.92%3.81%9.73%1.22%
DE:DMPDE:DMP54NeutralEUR 1.69B13.5620.60%2.58%1.71%15.95%
DE:B8FKDE:B8FK48NeutralEUR 17.68M-1.50-110.30%―――
DE:EVTDE:EVT42NeutralEUR 484.66M-2.68-25.63%―-5.03%-13.63%

* Financial Sector Average

Performance Comparison

0%500%1000%DE:93M1DE:B8FKDE:EVTDE:PA8DE:DMPDE:SBXDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:93M1 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:93M1MPH Health Care AG34.2019.37130.55%
DE:B8FKBiofrontera AG2.910.196.99%
DE:EVTEvotec AG (UK)2.73-2.45-47.30%
DE:PA8PAION AG0.050.03283.33%
DE:DMPDermapharm Holding34.05-0.74-2.14%
DE:SBXSynBiotic SE0.11-1.97-94.52%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 17, 2026